[go: up one dir, main page]

BR9302386A - Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis - Google Patents

Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis

Info

Publication number
BR9302386A
BR9302386A BR9302386A BR9302386A BR9302386A BR 9302386 A BR9302386 A BR 9302386A BR 9302386 A BR9302386 A BR 9302386A BR 9302386 A BR9302386 A BR 9302386A BR 9302386 A BR9302386 A BR 9302386A
Authority
BR
Brazil
Prior art keywords
fucose
visceral leishmaniasis
human
mannose ligand
antigen
Prior art date
Application number
BR9302386A
Other languages
Portuguese (pt)
Inventor
De Souza Clarisa B Palatnik
Radovan Borojevic
Original Assignee
Univ Rio De Janeiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rio De Janeiro filed Critical Univ Rio De Janeiro
Priority to BR9302386A priority Critical patent/BR9302386A/en
Publication of BR9302386A publication Critical patent/BR9302386A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BR9302386A 1993-06-17 1993-06-17 Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis BR9302386A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9302386A BR9302386A (en) 1993-06-17 1993-06-17 Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR9302386A BR9302386A (en) 1993-06-17 1993-06-17 Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis

Publications (1)

Publication Number Publication Date
BR9302386A true BR9302386A (en) 1995-01-17

Family

ID=4056688

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9302386A BR9302386A (en) 1993-06-17 1993-06-17 Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis

Country Status (1)

Country Link
BR (1) BR9302386A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423529B1 (en) 1997-12-08 2002-07-23 Council Of Scientific & Industrial Research Composition useful for the early diagnosis of visceral leishmaniasis and a process for preparing the same
WO2008009088A2 (en) 2006-07-21 2008-01-24 Universidade Federal De Minas Gerais Vaccine composition and immunization method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423529B1 (en) 1997-12-08 2002-07-23 Council Of Scientific & Industrial Research Composition useful for the early diagnosis of visceral leishmaniasis and a process for preparing the same
WO2008009088A2 (en) 2006-07-21 2008-01-24 Universidade Federal De Minas Gerais Vaccine composition and immunization method

Similar Documents

Publication Publication Date Title
NL940016I1 (en) Human factor viii compositions containing these methods and materials for use in their preparation
BR9303433A (en) LINEAR VISCOELASTIC COMPOSITION FOR HYGIENE OR PERSONAL CARE, PROCESS FOR THE PROMOTION OF HYGIENE AND PERSONAL CARE, PROCESS FOR HAIR FIXATION, PROCESS FOR THE PROMOTION OF HYGIENE AND SKIN CARE, AND, USE OF A POLESS THICKENING AGENT
FI971440A7 (en) Method of use of the formulation against sexually transmitted diseases and the composition containing it
IL134888A0 (en) HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING THEM AND THERAPEUTIC USE THEREOF
BR9612309A (en) Compound use of a compound pharmaceutical composition aerosol combination pharmaceutical formulation and processes for the treatment of a human or animal individual with an anti-inflammatory and / or allergic condition and for the preparation of a compound
MA21488A1 (en) COMPOSITIONS FOR DARKING NATURAL FIBERS AND APPLICATION TO HUMAN HAIR.
IT1285002B1 (en) PESTICIDE COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS
BR9405669A (en) Powder composition to bleach hair or keratinous fiber and method of preparation and use thereof
US4534964A (en) Hair conditioning shampoo
EP0153734A2 (en) Improved hair conditioning shampoo
BR9510509A (en) Compound pharmaceutical or cosmetic composition Use of a composition and process to prevent and / or combat skin aging
AU553711B2 (en) Nail conditioning composition
BR9607180A (en) New compositions for hair relaxation and methods for their preparation
BR9602680A (en) Use of a skin care composition and skin care agent
BR9302386A (en) Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis
BR8901924A (en) COMPOSITION FOR HUMANIZING AND SOFTENING OF HUMAN SKIN AND PROCESS FOR THE PREPARATION OF N-ALCOXYALKYLAMIDE COMPOUND
BR9509750A (en) Compound processes for their preparation and for controlling animal pests or harmful fungi composition against animal pests or harmful fungi and use of compounds
BR9508395A (en) Chemical compound preparation thereof and use in pharmaceutical compositions
FI954192L (en) Amino acid-substituted benzoylguanidines, a method for their preparation, their use as a medicinal substance or diagnostic substance, and a medicinal substance containing them
IT1271271B (en) DEVICE FOR THE MIXING AND PREPARATION OF SLIDING MATERIALS
IT1266950B1 (en) OILY PREPARATION CONTAINING ANTIOXIDANT SUBSTANCES FOR HUMAN USE AND PROCEDURE FOR ITS PRODUCTION
FR2725367B1 (en) COSMETIC COMPOSITION COMPRISING A FILM-FORMING POLYMER AND A SILICONE COMPOUND
DE59407165D1 (en) Skin coloring powder mixture
Kero et al. Guinea pig maximization test open epicutaneous test and chamber test in induction of delayed contact hypersensitivity
BR8207145A (en) COSMETIC COMPOSITION FOR SKIN TREATMENT OR HAIR TREATMENT, PROCESS FOR MANUFACTURING COMPOUNDS, PROCESS FOR MANUFACTURING SUCH COSMETIC COMPOSITION, PROCESS FOR TREATING HAIR OR SKIN AND COMPOUND USE

Legal Events

Date Code Title Description
FA Application withdrawn